IMMIMMUTEP LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 17:58 | Immutep Corporate Presentation | Presentations | — | 03026 | |
| 30 July 2026, 18:24 | Immutep Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 24 July 2026, 19:01 | Abstract Accepted for Presentation at ESMO Congress 2026 | Company Administration | — | 12008 | |
| 14 July 2026, 22:11 | Fourth U.S. Patent Secured for Efti and PD-1 Combination | Company Update | — | 11001 | |
| 13 July 2026, 19:38 | TACTI-004 Update & Positive Mature Data from INSIGHT-003 | Company Update | MS | 11001 | |
| 1 July 2026, 18:14 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 17 June 2026, 18:22 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 16 June 2026, 18:16 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 15 June 2026, 18:19 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 10 June 2026, 18:19 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 10 June 2026, 03:58 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 9 June 2026, 18:13 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 9 June 2026, 18:12 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 5 June 2026, 03:30 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 4 June 2026, 18:23 | Immutep Presents Positive IMP761 Phase I Data at EULAR 2026 | Company Update | — | 11001 | |
| 30 May 2026, 03:03 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 28 May 2026, 19:18 | Efti immune activation associated with improved survival | Company Update | — | 11001 | |
| 28 May 2026, 04:51 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 11 May 2026, 18:16 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 30 Apr 2026, 19:21 | Immutep Receives Nasdaq Notice of Bid Price Deficiency | Company Administration | — | 12008 | |
| 30 Apr 2026, 19:01 | Immutep Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 27 Apr 2026, 18:15 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 27 Apr 2026, 18:13 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 23 Apr 2026, 18:15 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 22 Apr 2026, 20:05 | Abstract on Efti accepted for presentation at ASCO 2026 | Company Administration | — | 12008 | |
| 17 Apr 2026, 18:22 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 15 Apr 2026, 19:27 | Immutep receives FDA ODD for Efti in Soft Tissue Sarcoma | Company Update | MS | 11001 | |
| 13 Apr 2026, 18:17 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 10 Apr 2026, 18:19 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 8 Apr 2026, 20:06 | Immutep Investor Update | Company Update | — | 11001 | |
| 20 Mar 2026, 19:18 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 20 Mar 2026, 19:18 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 20 Mar 2026, 00:24 | Ceasing to be a substantial holder from IFL | Substantial Holders | — | 02003 | |
| 19 Mar 2026, 19:20 | Update on Phase I Study of IMP761 for Autoimmune Diseases | Company Update | MS | 11001 | |
| 19 Mar 2026, 19:19 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 19 Mar 2026, 19:16 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 19 Mar 2026, 05:16 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 18 Mar 2026, 04:16 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 17 Mar 2026, 19:20 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 13 Mar 2026, 19:57 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 13 Mar 2026, 19:57 | TACTI-004 to be discontinued following futility analysis | Company Update | MS | 11001 | |
| 11 Mar 2026, 20:58 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 7 Mar 2026, 04:35 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 25 Feb 2026, 20:07 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 11 Feb 2026, 19:20 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 6 Feb 2026, 19:19 | Immutep Achieves 50% Enrolment in Global TACTI-004-1L NSCLC | Company Update | MS | 11001 | |
| 5 Feb 2026, 19:15 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 29 Jan 2026, 22:36 | Immutep Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19002, 19007 | |
| 31 Dec 2025, 19:27 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 22 Dec 2025, 19:25 | Positive Update on IMP761 Phase 1 | Company Update | MS | 11001 |
1–50 of 82
1 / 2